These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9112381)

  • 41. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
    Cunha SR; Mayo KE
    Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lovastatin decreases prolactin and growth hormone gene expression in GH4C1 cells through a cAMP dependent mechanism.
    Lasa M; Chiloeches A; García N; Montes A; Toro MJ
    Mol Cell Endocrinol; 1997 Jun; 130(1-2):93-100. PubMed ID: 9220025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of the prolactin promoter in transfected GH3 cells by posterior pituitary cells.
    Steinmetz R; Gutierrez-Hartmann A; Bigsby RM; Ben-Jonathan N
    Endocrinology; 1994 Dec; 135(6):2737-41. PubMed ID: 7988465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of prolactin secretion by dopamine and vasoactive intestinal peptide at the level of the pituitary in the turkey.
    Youngren OM; Chaiseha Y; El Halawani ME
    Neuroendocrinology; 1998 Nov; 68(5):319-25. PubMed ID: 9822799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion.
    Martinez de la Escalera G; Weiner RI
    Endocr Rev; 1992 May; 13(2):241-55. PubMed ID: 1618163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs.
    Ishida M; Mitsui T; Izawa M; Arita J
    Mol Cell Endocrinol; 2013 Aug; 375(1-2):58-67. PubMed ID: 23701824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture.
    Ishida M; Mitsui T; Yamakawa K; Sugiyama N; Takahashi W; Shimura H; Endo T; Kobayashi T; Arita J
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1529-37. PubMed ID: 17925456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1.
    Fernández M; Sánchez-Franco F; Palacios N; Sánchez I; Cacicedo L
    J Mol Endocrinol; 2005 Jun; 34(3):699-712. PubMed ID: 15956341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
    Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
    Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
    McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR
    J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.
    Judd AM; Login IS; Kovacs K; Ross PC; Spangelo BL; Jarvis WD; MacLeod RM
    Endocrinology; 1988 Nov; 123(5):2341-50. PubMed ID: 2844508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release.
    Aihara K; Shimada J; Miwa T; Tottori K; Burris KD; Yocca FD; Horie M; Kikuchi T
    Brain Res; 2004 Apr; 1003(1-2):9-17. PubMed ID: 15019558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
    Castillo AI; Aranda A
    Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The D2 dopamine receptor mediates inhibition of growth in GH4ZR7 cells: involvement of protein kinase-C epsilon.
    Senogles SE
    Endocrinology; 1994 Feb; 134(2):783-9. PubMed ID: 7507837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells.
    Enjalbert A; Musset F; Chénard C; Priam M; Kordon C; Heisler S
    Endocrinology; 1988 Jul; 123(1):406-12. PubMed ID: 2454806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
    Merchant KM; Gill GS; Harris DW; Huff RM; Eaton MJ; Lookingland K; Lutzke BS; Mccall RB; Piercey MF; Schreur PJ; Sethy VH; Smith MW; Svensson KA; Tang AH; Vonvoigtlander PF; Tenbrink RE
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
    Aizawa T; Hinkle PM
    Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization.
    Schettini G; Cronin MJ; MacLeod RM
    Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of mitogen-activated protein kinase in cyclic adenosine 3',5'-monophosphate-induced hormone gene expression in rat pituitary GH(3) cells.
    Yonehara T; Kanasaki H; Yamamoto H; Fukunaga K; Miyazaki K; Miyamoto E
    Endocrinology; 2001 Jul; 142(7):2811-9. PubMed ID: 11416000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.